Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H21ClN2 |
| Molecular Weight | 300.826 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCCC1C2=C(NC3=C1C=C(Cl)C=C3)C=CC=C2
InChI
InChIKey=JFRLWWDJCFYFSU-UHFFFAOYSA-N
InChI=1S/C18H21ClN2/c1-21(2)11-5-7-14-15-6-3-4-8-17(15)20-18-10-9-13(19)12-16(14)18/h3-4,6,8-10,12,14,20H,5,7,11H2,1-2H3
| Molecular Formula | C18H21ClN2 |
| Molecular Weight | 300.826 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011 Jul 14 |
|
| Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs. | 2014 Jul |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:12:51 GMT 2023
by
admin
on
Fri Dec 15 16:12:51 GMT 2023
|
| Record UNII |
5B1UZF65WW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29756
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5B1UZF65WW
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
DTXSID20863518
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
2500
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
SUB06716MIG
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
CHEMBL1615350
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
21382
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
m659
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | Merck Index | ||
|
3717
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
100000084339
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
C004624
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY | |||
|
5310-55-4
Created by
admin on Fri Dec 15 16:12:51 GMT 2023 , Edited by admin on Fri Dec 15 16:12:51 GMT 2023
|
PRIMARY | |||
|
C80670
Created by
admin on Fri Dec 15 16:12:52 GMT 2023 , Edited by admin on Fri Dec 15 16:12:52 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
